Juanola Roura, Xavier <br/><br/>
[Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis].  [electronic resource] 

 -  Reumatologia clinica   
 - 113-23 p.  digital 
<br/><br/> Publication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1885-1398 
<br/><br/><label>Standard No.: </label>10.1016/j.reuma.2010.12.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Biological Therapy--methods<br/>Drug Therapy, Combination<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Infliximab<br/>Methotrexate--administration & dosage<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>Spondylarthritis--classification<br/>Sulfasalazine--administration & dosage<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors